The role of atrial fibrillation catheter ablation in patients with heart failure.

Journal Article (Journal Article;Review)

Atrial Fibrillation (AF) and heart failure (HF) with reduced ejection fraction (HFrEF) frequently coexist, resulting in significant morbidity and mortality. Therapeutic options for patients with AF and HFrEF are limited due to few antiarrhythmic drug (AAD) choices and historically equivocal effects of procedural interventions on mortality. However, recent randomized trials examining catheter ablation (CA) in AF patients with HFrEF have shown a beneficial effect on arrhythmic burden and HF symptoms, as well as an improvement in mortality. This review focuses on the role of CA for AF patients with HFrEF.

Full Text

Duke Authors

Cited Authors

  • Bernard, ML; Benn, F; Williams, CM; Hiltbold, AE; Rogers, PA; Polin, GM; Khatib, S; Al-Khatib, SM; Morin, DP

Published Date

  • 2021

Published In

Volume / Issue

  • 66 /

Start / End Page

  • 80 - 85

PubMed ID

  • 34332663

Electronic International Standard Serial Number (EISSN)

  • 1873-1740

Digital Object Identifier (DOI)

  • 10.1016/j.pcad.2021.06.002


  • eng

Conference Location

  • United States